A wealth of evidence now indicates that low-density lipoprotein (LDL) must
be modified to promote atherosclerosis, and that this may involve oxidants
released by phagocytes. Many studies of oxidative damage in atherosclerosis
previously have concentrated on damage by nonhalogenated oxidants, but HOC
l is a highly toxic oxidant produced by myeloperoxidase in phagocytes, whic
h is also likely to be important in the disease pathogenesis. Currently som
e controversy exists over the products resulting from reaction of HOCl with
LDL lipids, in particular regarding whether predominantly chlorohydrins or
lipid peroxides are formed. In this study LC-MS of phosphatidylcholines in
human LDL treated either with HOCl or the myeloperoxidase system was used
as a specific method to detect chlorohydrin and peroxide formation simultan
eously, and with comparable sensitivity. Chlorohydrin products from lipids
containing oleic, linoleic and arachidonic acids were detected, but no hydr
operoxides of linoleoyl or arachidonoyl lipids could be observed. This stud
y provides the first direct evidence that lipid chlorohydrins rather than p
eroxides are the major products of HOCl- or myeloperoxidase-treated LDL pho
spholipids. This in turn provides important information required for the st
udy of oxidative damage in vivo which will allow the type and source of oxi
dants involved in the pathology of atherosclerosis to be investigated. (C)
2000 Elsevier Science Inc.